Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT138810271414N8
IRCT138810271414N8
Completed
未知

Autologous mesenchymal stem cell transplantation in the treatment of type 1 diabetic patients

Endocrinology & Metabolism Research Center0 sites20 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsType 1 diabetes.Insulin-dependent diabetes mellitus

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 1 diabetes.
Sponsor
Endocrinology & Metabolism Research Center
Enrollment
20
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Endocrinology & Metabolism Research Center

Eligibility Criteria

Inclusion Criteria

  • •signing informed consent, presence of type 1 diabetes, age 5\-30 years, duration of diabetes up to 20 weeks, being in stages before the onset of severe irreversible complications
  • •Exclusion criteria: history of DKA presentation, having acute infectious diseases

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Transplantation of Autologous Stem Cells for the treatment of corneal diseases
EUCTR2018-000523-14-ESniversidad Miguel Hernandez30
Completed
Early Phase 1
Investigation on autologous mesenchymal stem cell transplantation in diabetic retinopathydiabetic retinopathy (dibetes type one).Diabetic retinopathyH36.0*
IRCT201111291414N29The EMRI Endocrinology and Metabolism Research Institute ? Tehran University of Medical Sciences20
Completed
Phase 2
Effect of mesenchymal stem cells transplantation to improve of diabetic neuropathyDiabetic neurophaty.Diabetic polyneuropathy (E10-E14 with common fourth character .4+)G63.2*
IRCT201103171414N23???Endocrinology & Metabolism Research Institute Tehran University Of Medical Sciences20
Completed
Early Phase 1
Investigation on autologous mesenchymal stem cell transplantation in diabetic nephrophaty (type one)Diabetes Nephropathy (type 1).Glomerular disorders in diabetes mellitus
IRCT201111291414N28Endocrinology and Metabolism Research Institute (EMRI)20
Completed
Not Applicable
Autologous mesenchymal cell implantation in patients with peripheral artery disease (Arteriosclerosis obliterans, Buerger's disease, collagen disease)Peripheral artery disease (arteriosclerosis obliterans, Buerger&#39s disease, collagen disease)
JPRN-UMIN000013820Showa University Fujigaoka Hospital10